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Abstract: The endoplasmic reticulum (ER) is a complex protein folding and trafficking organelle.
Alteration and discrepancy in the endoplasmic reticulum environment can affect the protein folding
process and hence, can result in the production of misfolded proteins. The accumulation of
misfolded proteins causes cellular damage and elicits endoplasmic reticulum stress. Under such
stress conditions, cells exhibit reduced functional synthesis, and will undergo apoptosis if the stress
is prolonged. To resolve the ER stress, cells trigger an intrinsic mechanism called an unfolded protein
response (UPR). UPR is an adaptive signaling process that triggers multiple pathways through the
endoplasmic reticulum transmembrane transducers, to reduce and remove misfolded proteins and
improve the protein folding mechanism, in order to improve and maintain endoplasmic reticulum
homeostasis. An increasing number of studies support the view that oxidative stress has a strong
connection with ER stress. During the protein folding process, reactive oxygen species are produced
as by-products, leading to impaired reduction-oxidation (redox) balance conferring oxidative stress.
As the protein folding process is dependent on redox homeostasis, the oxidative stress can disrupt
the protein folding mechanism and enhance the production of misfolded proteins, causing further ER
stress. It is proposed that endoplasmic reticulum stress and oxidative stress together play significant
roles in the pathophysiology of bowel diseases.
Keywords: endoplasmic reticulum stress; unfolded protein response; oxidative stress; antioxidant
mechanisms; misfolded protein; inflammatory bowel disease
1. Introduction
Endoplasmic reticulum (ER) is a vital cellular organelle in eukaryotes. It serves an important
role in protein biosynthesis and post-translational modification processes. After transcription, the
messenger ribonucleic acids are translocated to ER for translation, to produce a nascent protein [1].
Post-translational processes, such as disulfide bonding and N-glycosylation, produce mature, unique,
and functional proteins [1]. Any discrepancy in the endoplasmic reticulum has an adverse impact on
the protein biosynthesis and modification process, resulting in the production of misfolded proteins.
Most misfolded proteins do not have a particular function in the cellular metabolism. Therefore, they
are subjected to either refolding or degradation [1].
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ER stress (ERS) arises after the accumulation of misfolded proteins in the ER. ERS can reduce
the production of functional proteins and even lead to apoptosis. To relieve the cell from ERS, an
evolutionarily conserved mechanism called the unfolded protein response (UPR) is activated [2]. UPR
consists of numerous complex, multifactorial, and parallel pathways that act to reduce and remove
misfolded proteins. UPR triggers multiple mechanisms to decrease protein synthesis, enhance the
protein folding mechanism, and remove the terminal misfolded protein [2,3].
ERS has been linked to oxidative stress (OS) in the pathophysiology of numerous diseases. OS
is a form of cellular damage caused by excess production and an accumulation of reactive oxygen
species (ROS) that overwhelm the already compromised antioxidant defence mechanism. ROS are free
radicals that are produced as a by-product of cellular metabolism. A number of biological disorders
and external agents are known to upregulate the production of ROS. Recent studies show that OS
can elicit a reduction-oxidation (redox) imbalance and worsen ERS through reducing the efficiency of
protein folding pathways and increasing the production of misfolded proteins [4].
In the present review, we summarize our current knowledge on the correlation between the ERS
and OS, as well as the signaling mechanisms triggered in response to both ERS and OS.
2. Endoplasmic Reticulum
ER is the major organelle in eukaryotes that is responsible for protein biosynthesis and
modification, including the translation of messenger ribonucleic acid (mRNA), protein glycosylation,
disulfide bonding, and post-translational modifications [5]. Besides protein biosynthesis, ER also plays
a significant role in calcium storage, lipid biosynthesis, detoxification, and energy metabolism, as well
as nucleus-cytosol signaling [6,7].
ER is also responsible for the quality control of the proteins produced. Several complex
mechanisms tightly regulate the protein trafficking in the ER [8], as shown in Figure 1. Under
these quality control mechanisms, only correctly folded proteins can be transported out of the
ER, while the misfolded proteins are either refolded or undergo ER-Associated Degradation
(ERAD) [8–10]. Therefore, it is crucial for the ER to differentiate the misfolded proteins from those
which are correctly folded and nascent. Nascent proteins display an addition of N-acetylglucosamine-
mannose-glucose [11]. Only correctly folded proteins undergo glucosidase cleavage and are
translocated to the Golgi complex [8,10]. Meanwhile, misfolded proteins are recognized by their
abnormal hydrophobic bonds via the chaperones that reside inside the ER [8]. These misfolded
proteins are prevented from exiting the ER by Calnexin/Calreticulin (Cnx/Crt) [8].
To ascertain that functional and mature proteins are being produced, the ER contains several
molecular chaperones that support protein biosynthesis. These chaperones include Heat Shock
Proteins (HSP) such as HSP33, HSP60, HSP70, HSP90, and others. HSP33 holds and prevents
protein aggregation and Protein Disulfide Isomerase (PDI), which regulates disulfide bonds within
a polypeptide [2,8,12,13]. These chaperones play a fundamental role in maintaining ER homeostasis.
Studies have shown that an interruption in the functional properties of chaperones can cause
significant impacts on cell homeostasis. For instance, the in vitro chemical inhibition of chaperones
(using tunicamycin) results in the inhibition of N-glycosylation activity in the protein, causing an
accumulation of misfolded proteins [8]. It must be noted that the protein and gene expression of these
chaperones demonstrate a significant elevation when the cells contain misfolded proteins in the ER [8].
Therefore, such chaperones are considered as markers for the misfolded protein assays [8].
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Figure 1. Protein trafficking in ER. Post mRNA translation, the nascent protein is transferred into the 
ER via the Sec61 channel, followed by the OST-mediated addition of N-acetylglucosamine residue on 
the protein. Glucose present on the oligosaccharide core undergoes glycosylation. The protein is then 
folded, and the disulfide bond is formed within the protein to stabilize its structure. Further, the 
correctly folded protein is cleaved and transported to the Golgi apparatus for further modifications. 
On the other hand, the misfolded protein rebinds to Cnx/Crt and is subjected to the refolding process. 
However, if the protein is recognized as terminally misfolded, it will be removed from the ER and 
subjected to ER-Associated Degradation (ERAD). * Cnx, Calnexin; COPII, Coat Protein II; Crt, 
Calreticulin; EDEM, ER Degradation Enhancer- α-Mannosidase; ERGIC53, ER-Golgi Intermediate 
Compartment 53 kDa Protein; ERGL, ERGIC53-like Protein; Erp57, ER-located PDI 57 kDa Protein; 
GlcI, Glucosidase I; GlcII, Glucosidase II; OST, Oligosaccharide transferase; UGTI, Uridine 
Diphosphate Glucose:glycoprotein Glycosyltransferase; VIP36, Vesicular Integral-membrane Protein 
36. 
3. Endoplasmic Reticulum Stress 
The protein folding process in the ER is crucial and acutely sensitive to intracellular and 
extracellular stimuli, such as the ER calcium ion, energy storage and redox homeostasis, elevation in 
mRNA translation, cytotoxicity, and inflammation [14–16]. A few misfolded proteins are commonly 
found in the ER [2,17]. Numerous studies have demonstrated that any interruption in the protein 
biosynthesis, such as an abnormal elevation in the protein biosynthesis, inhibition of the disulfide 
bond formation, metabolic energy depletion, and perturbation in N-glycosylation, can lead to the 
formation of a misfolded protein [2,17]. Importantly, the protein misfolding rate is directly 
proportional to the complexity and amount of the protein synthesized [8,17]. For instance, goblet cells 
have a higher amount of misfolded proteins and are more susceptible to the accumulation of 
misfolded proteins compared to other cells, since goblet cells secrete an abundant amount of complex 
mucin MUC2 protein [8,17]. In normal conditions, the ER has an advanced protein quality control 
mechanism to refold and remove the misfolded protein [8,17,18]. However, ER homeostasis can still 
be compromised if the protein misfolding rate exceeds the normal threshold of refolding, causing the 
accumulation of misfolded proteins, and leading to an unusual phenomenon known as ERS. 
ERS not only affects cellular homeostasis, but also cellular morphology. As shown in Figure 2, 
cells that undergo ERS have an altered ER morphology, such as luminal swelling and atypical 
structures [19]. ERS has an enormous impact on overall cellular processes. It is known to reduce the 
functional transcription and translation processes, as well as the intracellular and extracellular 
signaling pathways [6]. As a result, it can lead to various diseases [6]. 
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Figure 1. Protein trafficking in ER. Post mRNA translation, the nascent protein is transferred into the
ER via the Sec61 channel, followed by the OST-mediated addition of N-acetylglucosamine residue
on the protein. Glucose present on the oligosaccharide core undergoes glycosylation. The protein is
then folded, and the disulfide bond is formed within the protein to stabilize its structure. Further, the
correctly folded protein is cleaved and transported to the Golgi apparatus for further odifications.
On the other hand, the misfolded protein rebinds to Cnx/Crt and is subjected to the refolding
process. However, if the protein is recognized as terminally misfolded, it will be removed from
the ER and subjected to ER-Associated Degradation (ERAD). * Cnx, Calnexin; COPII, Coat Protein II;
rt, Calreticulin; EDEM, ER Degradation Enhancer- α-Mannosidase; ERGIC53, ER-Golgi Inter ediate
o art e t 53 k a rotei ; , I 53-like rotei ; r 57, -locate I 57 k a rotei ;
lcI, Glucosidase I; GlcII, Glucosidase II; OST, Oligosaccharide transferase; UGTI, Uridine Diphosphate
Glucose:glycoprotein Gl c syltra sferase; VIP36, Vesicular Integral-membrane Protein 36.
3. Endoplasmic Reticulum Stress
The protein folding process in the ER is crucial and acutely sensitive to intracellular and
extracellular stimuli, such as the ER calcium ion, energy storage and redox homeostasis, elevation in
mRNA translation, cytotoxicity, and inflammation [14–16]. A few misfolded proteins are commonly
found in the ER [2,17]. Numerous studies have demonstrated that any interruption in the protein
biosynthesis, such as an abnormal elevation in the protein biosynthesis, inhibition of the disulfide bond
formation, metabolic energy depletion, and perturbation in N-glycosylation, can lead to the formation
of a misfolded protein [2,17]. Importantly, the protein misfolding rate is directly proportional to the
complexity and amount of the protein synthesized [8,17]. For instance, goblet cells have a higher
amount of misfolded proteins and are more susceptible to the accumulation of misfolded proteins
compared to other cells, since goblet cells secrete an abundant amount of complex mucin MUC2
protein [8,17]. In normal conditions, the ER has an advanced protein quality control mechanism to
refold and remove the misfolded protein [8,17,18]. However, ER homeostasis can still be compromised
if the protein misfolding rate exceeds the normal threshold of refolding, causing the accumulation of
misfolded proteins, and leading to an unusual phenomenon known as ERS.
ERS not only affects cellular homeostasis, but also cellular morphology. As shown in Figure 2,
cells that undergo ERS have an altered ER morphology, such as luminal swelling and atypical
structures [19]. ERS has an enormous impact on overall cellular processes. It is known to reduce
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Figure 2. Comparison between a normal and ER stressed cell. Compared to the normal cell, the ER 
stressed cell exhibits a significant difference in the ER structure, including luminal swelling and a 
dissociated ribosome. 
4. Unfolded Protein Response (UPR) 
To help resolve ERS, cells develop a network of parallel, independent, and multifactorial 
signaling and transcriptional pathways known as the UPR. The UPR consists of numerous 
transcription factors and enzymes, which have been successfully discovered and well-studied over 
several decades [6,20,21]. UPR is aimed at relieving the ERS by decreasing the translation and 
transcription of general proteins, accelerating the ER protein folding and refolding ability, and 
enhancing ERAD to remove and reduce the accumulation of misfolded proteins in the ER. However, 
if the stress condition is too severe, or the UPR is impaired, then the UPR fails to alleviate the 
misfolded protein. As a consequence, the apoptotic signaling mechanism is triggered [6,20]. 
The UPR process has a critical major player known as Glucose Regulated Protein 78 (GRP78). 
GRP78 plays a pivotal role in the quality control of protein biosynthesis, including protein synthesis, 
folding, and assembly [18]. Additionally, GRP78 acts as an initiator of the UPR signaling pathway. It 
is established that there are three ER-localized transmembrane signal transducers that initiate the 
UPR [22–24]. These transducers are known as Inositol Requiring Kinase 1 (IRE1), Protein Kinase-like 
ER Kinase (PERK), and Activating Transcription Factor 6 (ATF6) [22–24]. These are constitutively 
expressed in the cells, but are tightly bounded by GRP78, and hence, are inactive under normal 
conditions [8,25,26]. Once misfolded proteins are formed in the ER, GRP78 unbinds and releases these 
transducers to locate and bind the misfolded proteins [26]. This event activates the transducers and 
results in the UPR downstream signaling pathways [26,27], as depicted in Figure 3. 
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Figure 2. Comparison between a normal and ER stressed cell. Compared to the normal cell, the ER
stressed cell exhibits a significant difference in the ER structure, including luminal swelling and a
dissociated ribosome.
4. Unfolded Protein Response (UPR)
To help resolve ERS, cells develop a network of parallel, independent, and multifactorial signaling
and transcriptional pathways known as the UPR. The UPR consists of numerous transcription factors
and enzymes, which have been successfully discovered and well-studied over several decades [6,20,21].
UPR is aimed at relieving the ERS by decreasing the translation and transcription of general proteins,
accelerating the ER protein folding and refolding ability, and enhancing ERAD to remove and reduce
the accumulation of misfolded proteins in the ER. However, if the stress condition is too severe, or the
UPR is impaired, then the UPR fails to alleviate the misfolded protein. As a consequence, the apoptotic
signaling mechanism is triggered [6,20].
The UPR process has a critical major player known as Glucose Regulated Protein 78 (GRP78).
GRP78 plays a pivotal role in the quality control of protein biosynthesis, including protein synthesis,
folding, and assembly [18]. Additionally, GRP78 acts as an initiator of the UPR signaling pathway.
It is established that there are three ER-localized transmembrane signal transducers that initiate the
UPR [22–24]. These transducers are known as Inositol Requiring Kinase 1 (IRE1), Protein Kinase-like
ER Kinase (PERK), and Activating Transcription Factor 6 (ATF6) [22–24]. These are constitutively
expressed in the cells, but are tightly bounded by GRP78, and hence, are inactive under normal
conditions [8,25,26]. Once misfolded proteins are formed in the ER, GRP78 unbinds and releases these
transducers to locate and bind the misfolded proteins [26]. This event activates the transducers and
results in the UPR downstream signaling pathways [26,27], as depicted in Figure 3.
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Figure 3. The UPR downstream signaling pathway. The UPR signal transducers, PERK, IRE1, and 
ATF6, are bounded by GRP78 under the normal condition. The accumulation of misfolded proteins 
triggers GRP78 to release and activate the UPR signal transducers to bind to the misfolded proteins, 
hence activating the UPR downstream signaling pathways. In the IRE1 pathway, IRE1 cleaves and 
releases XBP1 mRNA, which is translated to the active XBP1 protein that enhances the expression of 
UPR target genes. Meanwhile, PERK phosphorylates eIF2 and inhibits general mRNA translation, 
while upregulating the gene expression of resident ER proteins, hence reducing the ER workload to 
relieve the ERS. On the other hand, ATF6 migrates to the Golgi apparatus and is cleaved by the S1P 
and S2P protein, to expose its bZIP domain. Activated ATF6 is translocated to the nucleus and acts as 
a transcription factor to enhance the gene expressions of several ER resident proteins that contribute 
to protein folding, secretion, modification, and ERAD processes. * bZIP, Basic Leucine Zipper; eIF2, 
Eukaryotic Initiation Factor 2; ERAD, ER-associated Degradation; S1P, Sphingosine-1-Phosphate; 
S2P, Sphingosine-2-Phosphate. 
4.1. Inositol-Requiring Protein 1 (IRE1) 
IRE1 is an endoribonuclease that is localized in the ER membrane. It is the first component of 
the UPR signaling transducer that was discovered in Saccharomyces cerevisiae in 1990 via genetic 
screening in the UPR signaling model, and was found to be a proximal sensor of the UPR [28–30]. It 
is also the most conserved ERS transducer [28,29]. Recently, two isoforms of IRE1 have been 
identified, named IRE1α and IRE1β, and are encoded by differences in their genome and expression 
profiles [8,18]. Among these isoforms, IRE1α is highly conserved and constitutively expressed in 
eukaryotic cells [18]. 
IRE1 contains a Ser/Thr kinase domain and an endoribonuclease domain in its cytosolic part. As 
depicted in Figure 3, in a stress-free environment, IRE1 remains in an inactivated form due to the 
association between its cytoplasmic endoribonuclease domain and GRP78 [8,31]. In ERS, the 
dissociation of GRP78 from IRE1, and the subsequent binding of GRP78 to the misfolded proteins, 
results in an indirect activation of IRE1 [32,33]. Moreover, specific homodimerization and auto-
phosphorylation processes play a pivotal role in the activation of IRE1. The endonuclease activity of 
activated IRE1 cleaves a 26 bp intron from mRNA, encoding a specific basic leucine zipper-containing 
transcription factor, also known as X-Box Binding Protein-1 (XBP1) [6,34,35]. These events trigger a 
translational frameshift, leading to the production of activated forms of the XBP1 protein [6,34,35]. 
Activated XBP1 is a crucial transcriptional factor required for the activation of numerous UPR target 
genes that are known to regulate ER protein folding, ERAD, ER membrane expansion, and 
phospholipid synthesis, as well as protein intracellular-extracellular translocation [14]. XBP1 directly 
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Figure 3. The UPR downstream signaling pathway. The UPR signal transducers, PERK, IRE1, and
ATF6, are bounded by GRP78 under the normal condition. The accumulation of misfolded proteins
triggers GRP78 to release and activate the UPR signal transducers to bind to the misfolded proteins,
hence activating the UPR downstream signaling pathways. In the IRE1 pathway, IRE1 cleaves and
releases XBP1 mRNA, which is translated to the active XBP1 protein that enhances the expression of
UPR target genes. Meanwhile, PERK phosphorylates eIF2 and inhibits general mRNA translation,
while upregulating the gene expression of resident ER proteins, hence reducing the ER workload to
relieve the ERS. On the other hand, ATF6 migrates to the Golgi apparatus and is cleaved by the S1P
and S2P protein, to expose its bZIP domain. Activated ATF6 is translocated to the nucleus and acts as
a transcription factor to enhance the gene expressions of several ER resident proteins that contribute
to protein folding, secretion, modification, and ERAD processes. * bZIP, Basic Leucine Zipper; eIF2,
Eukaryotic Initiation Factor 2; ERAD, ER-associated Degradation; S1P, Sphingosine-1-Phosphate;
S2P, Sphingosine-2-Phosphate.
4.1. Inositol-Requiring Protein 1 (IRE1)
IRE1 is an endoribonuclease that is localized in the ER membrane. It is the first component of
the UPR signaling transducer that was discovered in Saccharomyces cerevisiae in 1990 via genetic
screening in the UPR signaling model, and was found to be a proximal sensor of the UPR [28–30]. It is
also the most conserved ERS transducer [28,29]. Recently, two isoforms of IRE1 have been identified,
named IRE1α and IRE1β, and are encoded by differences in their genome and expression profiles [8,18].
Among these isoforms, IRE1α is highly conserved and constitutively expressed in eukaryotic cells [18].
IRE1 contains a Ser/Thr kinase domain and an endoribonuclease domain in its cytosolic part.
As depicted in Figure 3, in a stress-free environment, IRE1 remains in an inactivated form due
to the association between its cytoplasmic endoribonuclease domain and GRP78 [8,31]. In ERS,
the dissociation of GRP78 from IRE1, and the subsequent binding of GRP78 to the misfolded
proteins, results in an indirect activation of IRE1 [32,33]. Moreover, specific homodimerization and
auto-phosphorylation processes play a pivotal role in the activation of IRE1. The endonuclease
activity of activated IRE1 cleaves a 26 bp intron from mRNA, encoding a specific basic leucine
zipper-containing transcription factor, also known as X-Box Binding Protein-1 (XBP1) [6,34,35]. These
events trigger a translational frameshift, leading to the production of activated forms of the XBP1
protein [6,34,35]. Activated XBP1 is a crucial transcriptional factor required for the activation of
numerous UPR target genes that are known to regulate ER protein folding, ERAD, ER membrane
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expansion, and phospholipid synthesis, as well as protein intracellular-extracellular translocation [14].
XBP1 directly or indirectly binds to several transcriptional factors associated with the UPR, resulting
in an increased expression of the target genes [8,18]. These target genes are involved in the ERAD
process; for instance, an in vitro study determined that stressed cells with mutated IRE1 or XBP1
release displayed defective ERAD [36].
The role of IRE1 in the activation of the inflammation and apoptotic signaling pathways is
well-established. Under ERS, IRE1 cleaves several ER-localized mRNAs, along with their RNase
domain, via a process called the Regulated IRE1-dependent Decay of mRNA [14,37]. It is hypothesised
that the IRE1-induced loss of ER-localized mRNAs triggers inflammation and apoptotic downstream
signaling, either via Tumour Necrosis Factor Alpha Receptor-associated Factor-2 (TRAF2) or the
c-Jun N-Terminal Kinase (JNK) pathway [14,37]. Moreover, IRE1 is also imperative in regulating the
homeostasis of intestinal epithelial cells. However, the precise mechanisms underlying the regulation
of homeostasis by IRE1 still remains obscure. A recent study by Zhang et al. found that IRE1 knockout
mice have a markedly reduced number of goblet cells and were highly susceptible to dextran sulfate
sodium-induced colitis [38]. Overall, the above findings demonstrate the potential importance of
IRE1/XBP1 pathways during the UPR and ER quality control mechanisms.
4.2. Protein Kinase-Like Endoplasmic Reticulum Kinase (PERK)
PERK, a type-1 ER-associated transmembrane protein, manages serine/threonine protein kinase
activity via its cytoplasmic domain [6]. Similar to IRE1, it is attached to GRP78, and therefore remains
in an inactivated mode under the stress-free condition (Figure 3) [39]. During the presence of misfolded
proteins, PERK is released and activated via dimerization and trans- auto-phosphorylation [25,40].
Activated PERK has a catalytic domain that shares a substantial homology with a heterotrimeric
protein known as Eukaryotic Translational Initiation Factor 2 on α Subunit at Ser51 (eIF2α) [25,40]. The
eIF2α is involved in the protein translation process via its reaction with methionyl-transfer Ribonucleic
Acid (Met-tRNA) and Guanosine Triphosphate, resulting in the formation of the eIF2α-GTP-Met-tRNA
complex [25,40,41]. This complex is required for the AUG initiation codon to recognize and bind the 60S
ribosomal subunit during mRNA translation [25,42]. The phosphorylation of eIF2α enables PERK to
attenuate mRNA translation, resulting in an abrogation of the protein synthesis and reduction in the ER
workload [43,44]. Although eIF2α phosphorylation attenuates the protein synthesis, phosphorylated
eIF2α is vital for the mRNA translation for Activating Transcription Factor 4 (ATF4) [25,42]. ATF4
is critical for the UPR downstream signaling. The 5′-untranslated region of ATF4 mRNA possesses
regulators of mRNA translation, known as the Upstream Open Reading Frame (uORF), and the
translation of uORFs leads to the missense mutation and attenuation of ATF4 translation [45,46].
However, during the UPR, eIF2α phosphorylation inhibits uORF, hence permitting the translation of
ATF4 [45,46]. Based on scientific evidence, ATF4, PERK, and eIF2α phosphorylation are essential for
the expression of genes that encode protein translocation and synthesis, an anti-oxidative response,
and apoptosis. [45,46]. Examples include Growth Arrest and DNA Damage 34 and the CAAT enhancer
binding homologous protein.
Interestingly, recent studies have revealed that other cytosolic kinases also phosphorylate eIF2α
at Ser51 under stress conditions. For instance, General Control Non-Repressed 2 Kinase is activated
by amino acid deficiency, Protein Kinase is stimulated by double-stranded RNA (dsRNA), and
heme-regulated eIF2α Kinase is initiated by heme-deprivation [14,47]. The initiation and regulation
of such mRNA translation processes via eIF2α kinase are collectively known as integrated stress
responses [14,47].
4.3. Activating Transcription Factor 6 (ATF6)
ATF6, the 90 kDa protein containing a transmembrane domain, is one of the UPR transducers [48].
Under the stress-free condition, it is localized to the ER membrane and bounded by GRP78 [8,48].
There are two distinct ATF6 isoforms in mammalian cells, ATF6α and ATF6β [49]. ATF6α plays a vital
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role in optimizing the protein folding process and ERAD [49,50]. It was shown that ATF6α knockout
mice were more vulnerable to ERS compared to wild-type mice, while mutated ATF6β mice displayed
no significant effect towards ERS [49,50]. On the other hand, the double knockout of ATF6α and ATF6β
caused embryonic lethality in mice; although the actual reason for this remains to be identified [14].
Unlike IRE1 and PERK, ATF6, following its dissociation with GRP78, gets transported to the
Golgi apparatus in response to the ERS (Figure 3) [6]. The N-terminal domain of ATF6 is cleaved
by sphingosine-1-phosphate and sphingosine-2-phosphate through the regulated intramembrane
proteolysis, forming an active ATF6 transcription factor in the cytoplasm [6,51] [24]. The active
ATF6 translocates to the nucleus and binds to the CAAT Binding Protein and ERS response
element 1, contributing to the upregulation of the target gene expression and the ER client protein
synthesis [24,52]. These ER client proteins include GRP78, ER Protein 99, and DnaJ HSP family
member C3 [14]. The involvement of ATF6α is crucial in relieving ERS due to its ability to improve
protein folding, post-translational modification, and trafficking [14]. Cao et al. reported that during
chronic ERS, ATF6α deficient mice have significantly higher mortality rates compared to the wild-type
mice [14]. Interestingly, ER-stressed transgenic ATF6α knockout mice exhibit an increased expression of
common ERS genes, like GRP78, but did not upregulate the production of XBP1 and ATF4, suggesting
the potential role of ATF6α in the regulation of XBP1 and ATF4 [53].
5. Protein Folding Challenge in Intestinal Secretory Cells
Secretory cells have a higher risk of ERS compared to other cell types, as they constantly produce
plenty of proteins. The secretory cells include plasma-and pancreatic β-cells, which manufacture
many antibodies and the insulin hormone. The heavy burden of protein synthesis is compensated
for by these secretory cells via advanced protein regulatory mechanisms, which optimize protein
folding and the elimination of misfolded proteins [1,54]. In the intestinal tract, secretory cells produce
complex proteins to maintain optimal intestinal conditions. One example of this is goblet cells, which
produce mucin glycoproteins, forming the mucosal barrier around the intestinal tract lumen, thus
defending the intestinal epithelial lining from luminal microbial flora [8]. Goblet cells are mainly
located throughout the intestine (small and large), from the duodenum to the rectum. Their synthesis
products, mucin glycoproteins, are complex proteins containing disulfide-linked homo-oligomers with
more than 5000 amino acids [55]. The production of mucin glycoproteins is elevated by toxins and
nervous stimuli [56,57]. There are several types of mucin glycoproteins produced by the goblet cells,
including mucin-type II (MUC2), MUC5AC, and MUC6 [55,58,59]. MUC2 is the most abundant type
of mucin glycoprotein and is found throughout the intestinal tract [55,58–60]. It has a central repetitive
region enriched with proline, serine, and threonine residues, that undergoes extensive glycosylation
and post-translational modifications during the protein folding process [58,59]. Despite the complexity
of MUC2 synthesis, it is constitutively secreted in high amounts, forming the major macromolecular
component of the mucosal barrier. Besides MUC2, goblet cells also produce other proteins, such
as Trefoil Factor 1 (TFF1), the Fc Fragment of Immunoglobulin G Binding Protein (FCGBP), and
Resistin-like Molecule β (RELMβ) [61]. The high demand of protein synthesis imposes a considerable
burden on the goblet cells, hence making them more susceptible to the ERS.
Recent studies utilizing mouse models document the potential role played by the goblet cells
during intestinal inflammation and ERS. Although multiple studies have been conducted so far, the
correlation between ERS, goblet cells, and inflammation remains obscure. MUC2 deficient mice were
reported to have spontaneous colitis and were more susceptible to dextran sulfate sodium-induced
colitis [62,63]. On the other hand, Gfi-deficient, as well as diphtheria toxin transgenic mice models with
no functional goblet cells, were not associated with spontaneous inflammation, suggesting a correlation
between the goblet cells and the release of pro-inflammatory cytokines, leading to inflammation [64,65].
As a shred of evidence, Winnie and Eeyore mouse models that have abnormalities in functional MUC2
production (due to point mutations in the MUC2 gene), exhibit spontaneous inflammation [56,66].
Although the ERS response is enhanced in these mouse models, it is yet to be confirmed whether
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the ERS response is caused by the spontaneous inflammation, is due to a malfunction in MUC2
glycoprotein synthesis, or is derived from both of these events [67]. Conversely, in the clinical studies,
ERS was observed to play a significant role in the intestinal inflammation. Intestinal biopsy samples
obtained from patients suffering from ulcerative colitis and Crohn’s disease had an elevated expression
of XBP1 [67,68]. Furthermore, polymorphism in the XBP1 gene was also detected in both of the
disorders. Three single nucleotide polymorphisms have been discovered in patients with ulcerative
colitis and Crohn’s disease, compared to normal individuals [67,68]. In Vitro studies revealed that these
single nucleotide polymorphisms reduce the activation of XBP1 and other UPR target genes [67,68].
Taken together, goblet cells play a critical part during ERS and intestinal inflammation; however,
further studies are warranted to confirm this hypothesis.
Similar to the goblet cells, paneth cells are also highly susceptible to the ERS. Paneth cells are
intestinal epithelial cells that form the lining of the small intestine and are also located at the base of
intestinal crypts. In the histological examination, these cells can be identified by their large eosinophilic
refractile granule that occupies most of the space in the cytoplasm. Paneth cells are important in
defending the intestinal tract via the production of antimicrobial proteins to eliminate gastrointestinal
pathogens and maintain homeostasis between the host and the microbe. Interestingly, Bertolotti et al.
reported that UPR plays a vital role in the maintenance of homeostasis in paneth cells [69]. It was
observed that mice with depleted Endoplasmic Reticulum to the Nuclear Signalling 2 (ERN2) gene
had little to no IRE1β protein expression [69]. Unlike IRE1α, which are expressed ubiquitously, IRE1β
are only expressed in the intestinal or lung epithelial cells [69]. These mutated mice were susceptible
to dextran sodium sulfate- induced colitis compared to the wild-type [69]. The study demonstrated
the influence of UPR pathways in maintaining homeostasis on the intestinal interface when exposed to
environmental microbes [69]. Furthermore, the significance of UPR in the development of paneth cells
was also found in a transgenic mouse model with XBP1 deletion [68]. In mice with an XBP1 deficiency,
the development of paneth cells was completely seized and distorted [68]. Microscopic evaluation
revealed a dramatic disorganization of the intestinal architecture, with a complete loss of functional
paneth cells in the intestinal tract [68]. Moreover, there was a decline in the number of goblet cells in
the intestinal tract [68]. These mice were also found to be highly susceptible to colitogenic stimuli and
microbiota-induced enteritis [68]. Overall, XBP1 perturbations can seize the development of paneth
cells, and thus compromise the immunological protection of the intestinal tract.
6. Endoplasmic Reticulum Stress and Autophagy
Autophagy is a naturally regulated, destructive cellular process that disassembles unwanted or
dysfunctional components of the body. It coordinates the degradation of organelles, proteins, and
lipids within the cells, to maintain the homeostatic function. Physiological perturbations include
starvation, ERS, and infection. During autophagy, intracellular debris and organelles are surrounded
and degraded by lysosomes [70]. Studies have proposed a substantial link between autophagy, UPR,
and ERS [71–74]. As mentioned earlier, the accumulation of unfolded and misfolded proteins during
ERS enforces a massive workload on the cells, especially secretory cells, which are known to produce
enormous quantities of proteins [75]. Interestingly, autophagy activities are also high in paneth cells,
and are thought to be useful for uncontrolled ERS [76,77]. Adolph et al. reported that Autophagy
Related Protein 16-1 (ATG16L1) deficient molecules exhibit discontinuous transmural ileitis similar to
the symptom observed in Crohn’s disease after an ERS challenge [76]. Additionally, under prolonged
ERS, UPR triggers the release of Ca2+, initiating the activation of Calcium/Calmodulin-dependent
Protein Kinase Kinase β (CaMKKβ) and 5′ Adenosine Monophosphate activated Protein Kinase
(AMPK) [78,79]. The activation of AMPK has an immense impact on autophagy as it initiates the
mammalian Target of Rapamycin (mTOR) pathway, which regulates cellular autophagy in mammalian
cells [70]. Furthermore, released calcium can also induce autophagy via the phosphorylation of Protein
Kinase C
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7. Oxidative Stress
Oxidative stress (OS) is a form of cellular stress and damage due to an imbalance between
antioxidant defense mechanisms and Reactive Oxygen Species (ROS) [81]. It commonly arises due to
the accumulation of ROS, exerting an oxidative reaction that overpowers the antioxidant activity in the
body [81]. A limited number of ROS are commonly found in the body as normal by-products of cellular
metabolism [42,82]. However, several factors are known to cause the abnormal production of ROS,
including irradiation [83,84]. Upregulation in numerous enzymatic processes, such as mitochondrial
respiration, arachidonic acid reaction, Nitric Oxide synthesis, glucose oxidation, and Fenton reactions,
also elevates the ROS levels in the body [83,85].
ROS accumulation has detrimental effects on cellular function and homeostasis. Studies
have demonstrated that ROS could trigger many cellular signaling pathways and induce damage
to DNA, proteins, and cells [81,86]. Persistent exposure to ROS upregulates the production of
oxidatively modified nucleic acids, proteins, and lipids, leading to the development of diseases [81,87].
To counteract ROS-induced disturbances, cells develop advanced antioxidant mechanisms to
scavenge and reduce ROS production. The antioxidant mechanisms are composed of enzymatic and
non-enzymatic reactions and are regulated by superoxide dismutase (SOD), glutathione/glutathione
disulfide (GSH/GSSG), and vitamins [18,82,88]. Under normal physiological conditions, the
antioxidant mechanisms maintain the redox homeostasis [88]. However, under a disease state,
underlying systemic and cellular disorders enhance ROS production and impair the antioxidant
mechanisms, causing ROS accumulation and redox imbalance, resulting in OS.
8. Vicious Sequence of Events between Endoplasmic Reticulum Stress and Oxidative Stress
The association between ERS and OS is yet to be fully elucidated. Recent studies support the
view that ER protein folding pathways are highly correlated with ROS production [4,87]. In ER, redox
homeostasis is crucial for the protein folding process and disulfide bond formation [89]. Studies
suggest that an alteration in ER-regulated protein folding pathways causes an ROS imbalance and
enhances ROS production, indirectly disturbing both ER and redox homeostasis [90]. ROS have a
profound effect on the ER protein folding process. It is known that several oxidants, including metal
ions, peroxides, and oxidation by-products, can pathologically initiate the UPR [14]. For instance,
ketocholesterol, a lipid oxidation by-product, can trigger severe UPR in macrophages and smooth
muscle cells; however, this response can be reversed by antioxidants like N-acetyl-cysteine [37,91,92].
In the protein folding process, disulfide bond formation is essential for the production of
functional, mature, and unique tertiary structured proteins, to stabilize the protein structure. The
disulfide bond formation is a reversible process for thiol-disulfide exchange and is catalyzed by
numerous ER oxidoreductases, such as ER Protein (ERP) 57 and ERP72 [93]. The protein folding process
is highly sensitive to redox homeostasis, hence its redox state is tightly modulated by numerous redox
mechanisms such as the GSSG/GSH cycle and Protein Disulfide Isomerase (PDI) reaction (kinetically
and thermodynamically) [94].
The GSSG/ GSH cycle has a pivotal role in regulating the protein folding process in the ER. GSH
is a non-protein thiol that can undergo oxidation and is converted in GSSG. The balance between GSH
and GSSG is crucial in maintaining redox homeostasis. The ratio of GSH to GSSG is approximately 1:1
in the ER lumen; meanwhile, it is approximately 50:1 in the cytoplasm [89]. Hence, it was suggested
that a highly oxidized environment optimizes the formation of the disulfide bond [89]. However, this
also creates an unfavourable environment for the antioxidant mechanism, as the interaction between
GSH and ROS is essential in maintaining ER redox homeostasis [82,89]. Besides, the environment also
disrupts the activities of ER-resident proteins, thus elevating the production of misfolded proteins and
causing ERS [82,89]. In the protein folding process, disulfide bonding is vital to modify and produce a
mature, stable, and functional protein. Issues in disulfide bonding, such as cysteine mispairing and
improper disulfide bonding, can produce misfolded proteins [82]. GSH can react and reduce non-native
disulfide bonds, allowing misfolded proteins to refold again [95].The proteins may be isomerized for
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protein refolding, oxidized for disulfide bonding, unfolded by GSH, or undergo ERAD [6,96]. However,
the protein refolding process is slow as it requires electron acceptors and is also highly dependent
on the redox reaction [6,96]. In the ERS condition, the microenvironment of ER is severely distorted.
Large amounts of misfolded proteins are accumulated in the ER. GSH assists in the protein unfolding
and refolding process [6,96]. Therefore, when the antioxidant mechanism of GSH is compromised,
an increased production of ROS leads to ERS.
Besides the GSH/GSSG reaction, PDI is also responsible for causing both ERS and OS. Similar to
the GSH/GSSG reaction, PDI is a multifunctional oxidoreductase chaperone protein that is involved in
the oxidative protein folding process [97]. It is used to catalyze the formation of disulfide bonds [97].
During the oxidative protein folding process, PDI receives two electrons from the polypeptide chain
substrate via cysteine residues, and is therefore able to oxidize the polypeptide chain substrate and
reduce the PDI protein active sites [97]. However, it has been proposed that other ER resident enzymes
also assist PDI in the oxidative folding process. For instance, ER Oxidoreductin 1 (ERO1) was found
to play an important role in assisting PDI in the oxidative folding process. After PDI receives the
electrons from the polypeptide substrate chain, ERO1 recruits Flavin Adenine Dinucleotide (FAD)
to conduct a redox reaction on PDI [97]. The redox reaction transfers the electrons to the oxygen
molecules, producing hydrogen peroxide, a type of ROS, and causes OS [97]. In a study by Tu et al.,
ERO1 null yeast and mice were found to have reduced ROS levels, compared to the control groups [94].
It was reported that about 25% of all the ROS in the in vitro yeast model were produced from an
ERO1 redox reaction during the disulfide bond formation [94]. This process enhances the production
of ROS and alters the redox balance in the ER. Moreover, the redox imbalance disturbs the protein
folding pathway, leads to the upregulation and accumulation of misfolded proteins, and thus induces
ERS. Interestingly, several other ER-resident enzymes play a role similar to ERO1, including quiescin
sulfhydryl oxidase, peroxiredoxin, and vitamin K epoxide reductase [98]. Figure 4 shows a summary
of the connection between ERS and OS.
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Figure 4. Schematic diagram of the impact of ERS on OS. During ERS, misfolded proteins are
accumulated in the ER. GSH helps to reduce the quantities of misfolded pr teins by converting
non-native disulfide bonds into native disulfide bonds. This event decreases the amount of GSH in
the cells. On the other hand, the PDI-FAD-EROI reaction also affects the redox balance in the cells.
During the oxidative folding process, PDI receives electrons from the polypeptide substrate chain.
FAD, which is r cruited by ERO1, conducts a redox reaction on the PDI and produces hydrogen
peroxide, which is a type of ROS. As a result, the levels of ROS are incre sed, while the amount
of GSH decreases. Therefore, it disturbs the redox balance and causes OS in the cells. * ERO1, ER
Oxidoreductin 1; FAD, Flavin Adenine Dinucleotide; GSSG/GSH, glutathione/glutathione disulfide;
PDI, Protein Disulfide Isomerase.
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9. Endoplasmic Reticulum Stress and Oxidative Stress in Inflammatory Bowel Disease
Studies on the role of ERS and OS in inflammatory disorders have been extensively conducted.
ERS and OS have been implicated by a number of research groups in the pathophysiology of
inflammatory conditions like hepatitis, pancreatitis, and inflammatory bowel disease (IBD) [17,99–103].
ERS is known to play a critical role in initiating the inflammatory response. UPR is reported
to play a key role in initiating inflammation in the cells. One of the UPR downstream pathways,
IRE1 signaling, is known to react with Tumour Necrosis Factor Receptor-associated Factor 2 and
initiates c-Jun N-terminal kinase (JNK) and the nuclear factor κ-light-chain-enhancer of activated
B cells (NF-κB)-induced inflammation signaling pathways [31,50]. It can also indirectly trigger the
release of pro-inflammatory genes by activating their gene promoters [104]. Besides, PERK pathways
also accelerate the migration of NF-κB to the nucleus via the phosphorylation of eIF2α and inhibition
of the production of the NF-κB inhibitor protein (inhibitor of κ-light-polypeptide-gene-enhancer in B
cells, thereby activating the NF-κB-induced inflammatory pathways) [105]. On the other hand, studies
have proposed that the ATF6 signaling pathway is also involved in inflammatory diseases. Activated
ATF6 is known to enhance the acute phase response in the liver, thus prolonging the inflammation and
causing unresolved inflammation [106].
The global burden of IBD, including ulcerative colitis and Crohn’s Disease, is steadily rising [107].
IBD is a chronic relapsing inflammation that causes the formation of ulcers in the gastrointestinal
tract, including the large and small intestines. Crohn’s disease can affect the entire gastrointestinal
tract, while ulcerative colitis is restricted to the large intestine [107]. Patients suffering from IBD
are reported to have ERS in the intestinal epithelial cells such as goblet cells, which produce mucin
proteins, such as MUC2 [8,20,108]. Disturbances in the intestinal epithelial cells can damage the
intestinal barrier, the mucosal immune system, and homeostasis, thus eliciting an immune response
and causing chronic inflammation. Since intestinal epithelial cells consistently produce mucin proteins,
they are highly vulnerable to ERS. Elevated levels of ERS markers have been reported in IBD patients,
as well as in mice models of colitis compared to the control groups [47,66,68,109–111]. Moreover,
ENU mutagenesis generated Winnie mice with an MUC2 mucin polymorphism leading to misfolded
MUC2 in goblet cells, exhibited ERS and IBD symptoms, including elevated misfolded proteins,
inflammation in the large intestine, and intestinal epithelial cell disruption [66]. Immunosuppressive
agents, such as glucocorticosteroid, has been commonly used in relieving IBD symptoms. Interestingly,
dexamethasone (glucocorticoid) treatment in Winnie mice reduced the number of misfolded MUC2
proteins and improved protein biosynthesis in the epithelial cells under in vitro and in vivo
conditions [112].
Previous studies have proposed that ERS and UPR are involved in the pathophysiology of
IBD, causing intestinal inflammation and the disruption of intestinal mucosal homeostasis. Several
UPR components have been reported to play a role in the pathophysiology of IBD. For instance,
mice with ablated DNA Damage-Inducible Transcript 3, one of the UPR downstream signaling
pro-apoptotic proteins, were more protective against dextran sodium sulfate-induced colitis [113].
Besides, IRE1-deficient mice were proven to display a reduction in intestinal epithelial cell apoptosis
and mucosal inflammation compared to the control group, after dextran sodium sulfate-induced
colitis [69]. IRE1 can cleave and inhibit MUC2 synthesis, and therefore, IRE1 omission is thought to
increase MUC2 production [114]. However, the removal of IRE1 could be harmful for IBD patients.
IRE1 is crucial when the cells are under an ERS condition, as it decreases the synthesis of MUC2 proteins,
resulting in the reduction of the ER workload and thereby relieving the ERS condition. Although UPR
is linked to IBD, several UPR components are shown to be vital in maintaining gastrointestinal tract
homeostasis. In genetically engineered mouse models, XBP1 knock-out mice displayed disruption
in gastrointestinal tract homeostasis, including apoptosis in the paneth cells, a reduction of goblet
cells, and ileitis [20,101]. Numerous non-synonymous Single Nucleotide Polymorphisms in XBP1
mRNA coding regions were discovered and reported in IBD patients, and it was proposed that
mutations in XBP1 can disrupt gastrointestinal tract homeostasis and cause IBD [68]. Another UPR
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transducer, Old Astrocytes Specifically Induced Substance (OASIS), is a transcription factor that
regulates tissue-specific UPR signalling and is localised in the ER membrane [115,116]. It contains
a bZIP domain, a transmembrane domain, and a transcription activation domain [115]. Under
an ERS condition, it is cleaved at the transmembrane region, leading to the release of its bZIP
domain-containing fragments [115]. These fragment are known to migrate into the nucleus and
upregulate the transcription of target genes. Asada and colleagues have discussed the possible role of
OASIS in the development of the gastrointestinal tract [117]. It was shown that OASIS-deficient mice
exhibit abnormalities in the differentiation of goblet cells in the large intestine [117]. Hence, it was
proposed that OASIS might be involved in the terminal differentiation of goblet cells [117]. Moreover,
Hino et al. documented that OASIS-deficient mice displayed severe damage in the mucosa of the
large intestine and a rapid infiltration of inflammatory cells into the lamina propria [115]. Based on
these findings, OASIS is thought to have a function towards the suppression of ERS; however, further
studies are warranted to validate these findings.
Interestingly, recent studies have reported the involvement of inflammasomes and ERS in
inflammatory pathways. Inflammasome is a signaling protein that consists of NOD-like receptors
(NLR), including caspase 1 and NLR Family Pyrin Domain Containing 3 (NLRP3) [118]. Once
activated, inflammasome is known to convert pro-caspase 1 into active caspase 1. Active caspase 1
subsequently activates pro-Interleukin (IL) 1β into active IL1β, which is one of the key mediators of
the inflammatory response. Inflammasome play a pivotal role in different inflammation-induced
autoimmune and metabolic disorders [119–121]. It has been hypothesized that ERS is strongly
associated with inflammasome during inflammation. For instance, several studies showed that ERS is
involved in the activation of pro-IL1β and NLRP3 [122–124]. Moreover, ERS was found to activate
the NLRP3 inflammasome in the human monocytic cell line (THP-1) [122,125]. Despite the proven
association between ERS and inflammasomes, studies are required to understand this correlation in
further detail.
Alongside ERS, OS is also known to cause inflammation. ROS can induce inflammation
by triggering JNK, Protein Kinase C, Growth factor Tyrosine Kinase Receptor, and Extracellular
signal-Regulated Kinase signaling pathways [14]. Several inflammatory transcription factors including
NF-κB are redox sensitive and trigger cellular inflammation [126]. IBD patients, as well as mice models
of IBD, have elevated levels of ROS in the intestinal mucosal tissue [14]. Mucosal inflammatory
pathways are proposed to enhance the production of ROS, such as superoxide and nitric oxide,
from intestinal cells, including gut macrophage and epithelial cells [127]. ROS accumulation can
damage the intestinal mucosal barrier and induce intestinal inflammation via lipid peroxidation
and protein modifications [14]. Therefore, the antioxidant defense mechanisms are necessary for
maintaining intestinal homeostasis. For example, genetically modified mouse models with Nuclear
Factor (erythroid-derived 2) Like 2 Factor (NRF2)-depletion increased the effect of dextran sodium
sulfate to induce colitis [128]. NRF2 is a transcription factor that regulates the antioxidant protein
expressions in response to the oxidative damage on the cells. Under the normal condition, NRF2 is
retained in the cytoplasm by Kelch-like ECH-Associated Protein 1 (KEAP1) and Cullin3 protein, that
degrades NRF2 and prevents the activation of associated downstream signaling pathways. During
cellular damage, KEAP1-Cullin3-induced NRF2 degradation is inhibited [129]. Consequently, NRF2 is
translocated to the nucleus and binds to the Antioxidant Response Element promoter, upregulating
the gene expressions for antioxidant proteins [129]. Overall, OS and ERS seem to play vital roles in
IBD pathophysiology.
10. Conclusions and Future Directions
Various scientific findings document a functional link between ERS and OS. However, the
mechanism behind such a correlation is yet to be fully elucidated. Future studies are warranted
to: understand the pathophysiology behind cellular stress-mediated alterations in the protein folding
processes, resulting in the production of misfolded proteins; and gain an in-depth understanding
Int. J. Mol. Sci. 2017, 18, 771 13 of 19
of the pathways to determine the precise mechanism(s) of the interactions between ERS and OS
signalling. Such findings would make a substantial contribution towards the ERS-OS field of
research, leading to the development of new therapeutic interventions for ERS- and OS- associated
inflammatory conditions.
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